Le Transmettre P/E de Corvel Corp. est N/A
Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
together, let's do more. corvel is a leader of risk and healthcare management solutions to employers, third party administrators, insurance companies and government agencies. we are publicly traded (nasdaq:crvl) and annual revenues exceeded $493 million in fy2015. our continued customer growth is a testament to our financial stability and our significant investments in new systems and technologies allows us to continue to deliver industry-leading solutions to the marketplace. corvel has approximately 3,500 associates who serve more than 2,000 customers through a national branch office network covering all 50 states.